Pomalidomide-PEG2-C2-NH2

Background Introduction

Pomalidomide-PEG2-C2-NH2 is a synthetic molecule designed as an E3 ligase ligand-linker conjugate, commonly used in the development of Proteolysis Targeting Chimeras (PROTACs). The pomalidomide moiety specifically recruits the cereblon (CRBN) E3 ubiquitin ligase, while the PEG2-C2-NH2 flexible linker allows for further functionalization and conjugation to target protein ligands. This modular construct plays a crucial role in targeted protein degradation research, which is an emerging therapeutic strategy in drug discovery.

Mechanism

The mechanism of action of Pomalidomide-PEG2-C2-NH2 is based on the ubiquitin-proteasome system. The pomalidomide unit binds selectively to the CRBN E3 ligase, acting as a recruiting element. The PEG2-C2 linker provides an ideal distance and flexibility for bifunctional assembly, enabling the conjugation of a ligand that binds to a protein of interest (POI). Upon formation of a PROTAC molecule, the E3 ligase is brought into close proximity with the POI, leading to ubiquitination of the target protein and its subsequent degradation by the proteasome.

Applications

Pomalidomide-PEG2-C2-NH2 is widely used in the synthesis of novel PROTACs for chemical biology and drug discovery applications. It enables the rapid development of PROTACs targeting a variety of disease-related proteins, including oncogenic kinases, transcription factors, and epigenetic regulators. The product is also valuable in mechanistic studies of ubiquitin-dependent protein degradation, validation of therapeutic targets, and in the development of next-generation therapeutics for cancer, neurodegenerative diseases, and immune disorders.

The Pomalidomide-PEG2-C2-NH2 E3 Ligase Ligand-Linker Conjugate is a versatile tool in the development of PROTACs, facilitating targeted protein degradation by recruiting E3 ligases to specific proteins. This molecule integrates a well-optimized linker, ligand, and reactive site, ensuring efficient and selective protein interaction for research applications.

Linker: The PEG2-C2 linker in this molecule is characterized by its moderate length and flexible nature, enhancing solubility and spatial arrangement. Its non-cleavable structure ensures stability and maintains the integrity of the conjugate during cellular processes.

Ligand: The ligand in this molecule is based on pomalidomide, a thalidomide analog known for its potent E3 ligase binding properties. Its structural features include a glutarimide ring, which is crucial for cereblon binding, facilitating effective recruitment of the E3 ligase complex.

Reactive Site: The NH2 group at the end of the molecule serves as the reactive site, enabling coupling with target protein ligands through amide bond formation. Recommended reaction types include amidation or reductive amination, which are reliable for forming stable linkages.

Recommended Target Protein Ligand: The molecule is compatible with electrophilic warheads, such as acrylamides or chloroacetamides, which can form covalent bonds with cysteine residues on target proteins. This approach offers advantages in terms of specificity and potency, making it suitable for applications in biochemical studies and the elucidation of protein function through degradation.